The Life Sciences industry has only recently started to embrace data as a strategic asset that can impact drug development, patient care and profit. As the industry catches up, data quality is still an industry challenge, hindering the ability to leverage more sophisticated technologies like AI.
At a time when the imperative of faster drug development in particular has become painfully evident, a number of functional areas are seizing opportunities to organize and apply their data in a systematic way for more efficient business operations.
Join us for a one hour live streamed industry forum where our panelists will discuss challenges they’ve faced with data quality, what they are doing to improve data quality, and how their data strategy is impacting their business.
Our panelists will cover:
- Common industry challenges with data quality
- How data quality impacts the value chain esp. the regulatory information management (RIM) process
- Framework for addressing data quality
- Industry success stories
- Best practices
- Live Q&A
Who should attend: Life Sciences & Medical devices industry executives (VPs to Associate Directors) across all functions that interact with institutional data:
- Research & Development (R&D)
- Regulatory Affairs
- Production (Manufacturing)
- Quality (including Validation)
Don’t miss this live streamed interactive panel discussion.